Clinical Trials in Cancer provides concise, accessible and practical information on the practicalities of planning, designing, conducting, analysing, reporting, and interpreting phase III clinical trials predominantly, but also single-arm and randomized phase II trials. The book shows clearly how recent developments and current thinking can be implemented. Information on the need to decide and measure realistic target differences in trials, the conduct and
interpretation of interim analyses, patient advocacy, good clinical practice, the study of quality of life, the role of meta-analyses, and informed consent and other ethical issues are also covered.
This book will prove invaluable for medical, statistical, and biological cancer researchers, health care professionals, and researchers in the pharmaceutical industry. Trial sponsors, principal investigators, members of data monitoring and trial supervisory committees, specialists invited to provide independent assessments, and many others involved in all aspects of research related to clinical trials should also find this book helpful.
Publisher: Oxford University Press
Number of pages: 386
Weight: 788 g
Dimensions: 247 x 173 x 26 mm
. . . excellent self-referencing . . . I would unequivocally recommend this book to those new to running clinical trials and to those with some experience. It is both very readable and also likely to be of use as a reference text. * Statistics in Medicine, 23 *
This book will prove invaluable for medical, statistical and biological cancer researchers, health care professionals, and researchers in the pharmaceutical industry. * Anticancer Research 23 *